Tag: maternal health

Why media narratives matter for safe abortion and reproductive justice in Zimbabwe

Healthtimes

By Memory Pamella Kadau “Abortion kills.” “Abortion is illegal.” “Abortion is a sin.” “Baby Dumped in Bush as Illegal Abortions Rise.” “Zimbabwe: Our Ugly Secret – Abortion, Illegal but Thriving.” “How Can Zimbabwe Allow Abortion When It Has Just Abolished the Death Penalty?” “Zimbabwe: Historic Victory for Reproductive Justice – High Court Ruling.” “New Abortion Guidelines Expand Choice in Zimbabwe.” These are the headlines that shape Zimbabwean opinions long before anyone reads the actual law. Media breaking stigma or building it? The media plays a key role in shaping public…

Read More

Why Reforming the Termination of Pregnancy Act Can No Longer Wait

Michael Gwarisa

By Edinah Masiyiwa I have been closely following recent developments on access to safe abortion for women and girls in Zimbabwe. As I reflect on the Women’s Action Group’s (WAG) campaign on safe abortion in the early 1990s, I am encouraged by how far the country has come on this issue. When WAG advocated for access to safe abortion then, the organisation faced intense opposition that ultimately silenced the public campaign. Quiet, behind-the-scenes advocacy continued, eventually resulting in post-abortion care being adopted as a key component of reproductive health services—an…

Read More

185 Nurses Graduate at Sally Mugabe Central Hospital

Kuda Pembere

By Kuda Pembere Two hundred and ten nurses graduated at Sally Mugabe Central Hospital on Friday, specializing in various disciplines that include General Nursing, Midwifery, Pediatric Nursing, Intensive Care Nursing (ICN), and Operating Theatre Nursing (OTN). Of these, 114 were general nurses, 55 midwives, 14 pediatric nurses, 14 intensive care nurses, and 13 operating theatre nurses. Officiating at the ceremony, Higher Life Foundation Country Director Philani Nyatsanza said the partnership between the foundation and the hospital began in 2021 to strengthen maternal and neonatal health services. “We believe that the…

Read More

Zimbabwe and UNFPA Begin Consultations for 9th Country Programme (2027–2031)

Michael Gwarisa

By Michael Gwarisa The Government of Zimbabwe and the United Nations Population Fund (UNFPA) have commenced consultations to develop the 9th Country Programme of Cooperation, which will run from 2027 to 2031. The two-day Stakeholder Engagement Workshop, taking place in Harare from 6 to 7 October 2025, brings together senior government officials, civil society, academia, youth representatives, and development partners to collectively shape the country’s future priorities for sexual and reproductive health and rights (SRHR), gender equality, and population dynamics. According to the concept note, the workshop seeks to “collectively…

Read More

Securing a Healthier Future: Global Leaders Target Malaria and Maternal & Child Health at UNGA80

Michael Gwarisa

New York, 24 September 2025 — On the sidelines of the 80th United Nations General Assembly (UNGA), world leaders and heads of state convened for a landmark event titled “Uniting for Global Health Security.” The gathering was jointly hosted by the Global Leaders Network (GLN) for Women’s, Children’s and Adolescents’ Health (WCAH) and the African Leaders Malaria Alliance (ALMA). The meeting came at a time when overlapping global crises are testing fragile health systems. From conflict and displacement to climate emergencies and economic shocks, resources are being diverted away from…

Read More

Zimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir

Michael Gwarisa

By Michael Gwarisa  Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…

Read More